Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%

NCT01892137 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Ingenol mebutate gel 0.05%

Sponsor

LEO Pharma